Impact of Burkholderia infection on lung transplantation in cystic fibrosis

被引:124
作者
Murray, Susan [1 ,2 ]
Charbeneau, Jeffery [1 ]
Marshall, Bruce C. [3 ]
LiPuma, John J. [4 ,5 ]
机构
[1] Univ Michigan, Sch Publ Hlth, Dept Biostat, Ann Arbor, MI 48109 USA
[2] Sci Registry Transplant Recipients, Ann Arbor, MI USA
[3] Cyst Fibrosis Fdn, Bethesda, MD USA
[4] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA
[5] Univ Michigan, Sch Med, Dept Pediat & Communicable Dis, Ann Arbor, MI 48109 USA
关键词
infection; lung allocation; transplant benefit; Burkholderio;
D O I
10.1164/rccm.200712-1834OC
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Rationale: Lung transplantation offers the only survival option for patients with cystic fibrosis (CF) with end-stage pulmonary disease. Infection with Burkholderia species is typically considered a contraindication to transplantation in CF. However, the risks posed by different Burkholderia species on transplantation outcomes are poorly defined. Objectives: To quantify the risks of infection with Burkholderia species on survival before and after lung transplantation in patients with CF. Methods: Multivariate Cox survival models assessed hazard ratios of infection with Burkholderia species in 1,026 lung transplant candidates and 528 lung transplant recipients. Lung allocation scores, incorporating Burkholderia infection status, were calculated for transplant candidates. Measurements and Main Results: Transplant candidates infected with different Burkholderia species did not have statistically different mortality rates. Among transplant recipients infected with B. cenocepacia, only those infected with nonepidemic strains had significantly greater post-transplant mortality compared with uninfected patients (hazard ratio [HR], 2.52; 95% confidence interval [CI], 1.04-6.12; P = 0.04). Hazards were similar between uninfected transplant recipients and those infected with B. multivorons (HR, 0.66; 95% CI, 0.27-1.56; P = 0.34). Transplant recipients infected with B. gladioli had significantly greater post-transplant mortality ;than uninfected patients (HR, 2.23; 95% CI, 1.05-4.74, P = 0.04). Once hazarclsfor species/strain were included, lung allocation scores of B. multivorans-infected transplant candidates were comparable to uninfected candidate scores, whereas those of candidates infected with nonepidemic B. cenocepacia or B. gladioli were lower. Conclusions: Post-transplant mortality among patients with CF infected with Burkholderia varies by infecting species. This variability should be taken into account in evaluating lung transplantation candidates.
引用
收藏
页码:363 / 371
页数:9
相关论文
共 43 条
[1]   Lung transplantation for cystic fibrosis patients with Burkholderia cepacia complex -: Survival linked to genomovar type [J].
Aris, RM ;
Routh, JC ;
LiPuma, JJ ;
Heath, DG ;
Gilligan, PH .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2001, 164 (11) :2102-2106
[2]   The effects of panresistant bacteria in cystic fibrosis patients on lung transplant outcome [J].
Aris, RM ;
Gilligan, PH ;
Neuringer, IP ;
Gott, KK ;
Rea, J ;
Yankaskas, JR .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1997, 155 (05) :1699-1704
[3]   Lung transplantation and life extension in children with cystic fibrosis [J].
Aurora, P ;
Whitehead, B ;
Wade, A ;
Bowyer, J ;
Whitmore, P ;
Rees, PG ;
Tsang, VT ;
Elliott, MJ ;
de Leval, M .
LANCET, 1999, 354 (9190) :1591-1593
[4]   Subdural empyema due to Burkholderia cepacia: An unusual complication after lung transplantation for cystic fibrosis [J].
BalfourLynn, IM ;
Ryley, HC ;
Whitehead, BF .
JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 1997, 90 :59-64
[5]   Bronchiolitis obliterans organizing pneumonia (BOOP) in lung transplant recipients [J].
Chaparro, C ;
Chamberlain, D ;
Maurer, J ;
Winton, T ;
Dehoyos, A ;
Kesten, S .
CHEST, 1996, 110 (05) :1150-1154
[6]   Infection with Burkholderia cepacia in cystic fibrosis -: Outcome following lung transplantation [J].
Chaparro, C ;
Maurer, J ;
Gutierrez, C ;
Krajden, M ;
Chan, C ;
Winton, T ;
Keshavjee, S ;
Scavuzzo, M ;
Tullis, E ;
Hutcheon, M ;
Kesten, S .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2001, 163 (01) :43-48
[7]   Endemicity and inter-city spread of Burkholderia cepacia genomovar III in cystic fibrosis [J].
Chen, JS ;
Witzmann, KA ;
Spilker, T ;
Fink, RJ ;
LiPuma, JJ .
JOURNAL OF PEDIATRICS, 2001, 139 (05) :643-649
[8]   Population structure analysis of Burkholderia cepacia genomovar III:: varying degrees of genetic recombination characterize major clonal complexes [J].
Coenye, T ;
LiPuma, JJ .
MICROBIOLOGY-SGM, 2003, 149 :77-88
[9]   Comparative assessment of genotyping methods for epidemiologic study of Burkholderia cepacia genomovar III [J].
Coenye, T ;
Spilker, T ;
Martin, A ;
LiPuma, JJ .
JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (09) :3300-3307
[10]  
COX DR, 1972, J R STAT SOC B, V34, P187